Related Experiment Video
Updated: Mar 30, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
NIM811 downregulates transforming growth factor‑β signal transduction in vivo and in vitro
Jing Chen1, Dian-Gang Liu2, Hui Wang1
1Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China.
Abstract:
Liver fibrosis is the common histological feature of a number of chronic liver diseases, and leads to cirrhosis and hepatocellular carcinoma (HCC). It has been demonstrated that N‑methyl‑4‑isoleucine cyclosporine (NIM811) attenuates CCl4‑induced liver fibrosis and inflammation in rats. The present study investigated whether NIM811 downregulated transforming growth factor (TGF)‑β signaling in rats with CCl4‑induced liver fibrosis and in HSC‑T6 cells. Liver tissues were obtained from rats with CCl4‑induced liver fibrosis, with or without NIM811 treatment. HSC‑T6 cells were cultured with or without NIM811 for 18 h under serum‑free conditions. Expression of collagen I, α‑smooth muscle actin (α‑SMA), TGF‑β1, TGF‑β receptor I (TβR‑I) and TGF‑β pathway downstream signaling molecules were measured by reverse transcription‑quantitative polymerase chain reaction and/or western blotting. Collagen I and TGF‑β1 content in the cell supernatant was measured by ELISA. NIM811 profoundly inhibited collagen I, α‑SMA, TGF‑β1 and TβR‑I expression in the liver of CCl4‑treated rats. Phosphorylation of Smad2, 3 and 1/5/8 was decreased in the liver of NIM811‑treated groups, accompanied by increased In addition, Smad7 expression compared with the CCl4‑treated rats. NIM811 inhibited collagen I, TGF‑β1 and TβR‑I expression in HSC‑T6 cells. Smad1 mRNA and phospho‑Smad1/5/8 protein levels decreased following NIM811 treatment, accompanied by increased Smad7 expression in HSC‑T6 cells compared with normal controls. Furthermore, NIM811 also inhibited collagen I mRNA expression in the liver of rats with CCl4‑induced liver fibrosis and in HSC‑T6 cells. The results suggest that the antifibrotic effect of NIM811 was due to the inhibition of TGF‑β1 and its downstream signaling molecules.
Insights
N‑methyl‑4‑isoleucine cyclosporine (NIM811) reduces liver fibrosis by inhibiting transforming growth factor (TGF)‑β signaling. This compound downregulates key fibrotic markers and downstream signaling molecules, offering potential therapeutic benefits for liver disease.
Area of Science:
- Hepatology and Gastroenterology
- Molecular Biology and Biochemistry
- Pharmacology and Drug Discovery
Background:
- Liver fibrosis, a precursor to cirrhosis and hepatocellular carcinoma (HCC), is a common outcome of chronic liver diseases.
- Transforming growth factor (TGF)-β signaling is a critical pathway implicated in the pathogenesis of liver fibrosis.
- N‑methyl‑4‑isoleucine cyclosporine (NIM811) has shown promise in attenuating liver fibrosis and inflammation.
Purpose of the Study:
- To investigate the mechanism by which NIM811 downregulates transforming growth factor (TGF)-β signaling in a rat model of CCl4-induced liver fibrosis.
- To examine the effects of NIM811 on TGF-β signaling pathway components in both in vivo liver tissues and in vitro HSC-T6 cells.
Main Methods:
- Utilized a carbon tetrachloride (CCl4)-induced liver fibrosis rat model and cultured HSC-T6 cells.
- Administered NIM811 to rats and HSC-T6 cells, assessing the expression of fibrotic markers (collagen I, α-SMA) and TGF-β signaling molecules (TGF-β1, TβR-I, Smad proteins).
- Employed reverse transcription-quantitative polymerase chain reaction (RT-qPCR), western blotting, and ELISA for molecular and protein analysis.
Main Results:
- NIM811 significantly inhibited the expression of collagen I, α-SMA, TGF-β1, and TβR-I in the livers of CCl4-treated rats.
- NIM811 treatment decreased the phosphorylation of Smad2, 3, and 1/5/8, while increasing Smad7 expression in both rat livers and HSC-T6 cells.
- NIM811 demonstrated inhibitory effects on collagen I, TGF-β1, and TβR-I expression in HSC-T6 cells, confirming its antifibrotic action.
Conclusions:
- The antifibrotic effects of NIM811 are attributed to its ability to inhibit the TGF-β1 signaling pathway.
- NIM811 effectively downregulates key fibrotic markers and downstream signaling molecules involved in liver fibrosis.
- These findings suggest NIM811 as a potential therapeutic agent for managing liver fibrosis.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Angiogenesis and Blood Supply
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

